ISRG241004C460000
- 27.12
- 0.000.00%
Intuitive Surgical Newsroom
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $550
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $550
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Teleflex (TFX)
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $494
Intuitive Surgical (ISRG) Receives a Buy From BTIG
Intuitive Surgical Analyst Ratings
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $494
BTIG Adjusts Price Target on Intuitive Surgical to $494 From $469, Maintains Buy Rating
Intuitive Surgical Analyst Ratings
Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $560
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $515
RBC Capital Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Intuitive Surgical Price Target Raised to $510.00/Share From $380.00 by Redburn Atlantic
Intuitive Surgical Analyst Ratings
Redburn Upgrades Intuitive Surgical to Buy, Cites Updated Guidance
Redburn Atlantic Upgrades Intuitive Surgical(ISRG.US) to Buy Rating, Announces Target Price $510
Redburn Atlantic Upgrades Intuitive Surgical to Buy From Neutral, Adjusts Price Target to $510 From $380
Daiwa Securities Adjusts Price Target on Intuitive Surgical to $460 From $430
Intuitive Surgical Analyst Ratings
Truist Financial Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $520